CD24 expression as a marker for predicting clinical outcome in human gliomas

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Deng, Jianping ^a   Gao, Guodong ^a   Wang, Liang ^a   Wang, Tao ^a   Yu, Jia ^a   Zhao, Zhenwei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CD24 PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BRAIN TISSUE; CANCER GRADING; FEMALE; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PARAMETERS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; BRAIN TUMOR; CASE CONTROL STUDY; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY;

ANTIGENS, CD24; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84863242872     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/517172     Document Type: Article

References (28)

1. Wick W., Platten M., Weller M., New (alternative) temozolomide regimens for the treatment of glioma Neuro-Oncology 2009 11 1 69 79
2. Rivera A. L., Pelloski C. E., Sulman E., Aldape K., Prognostic and predictive markers in glioma and other neuroepithelial tumors Current Problems in Cancer 2008 32 3 97 123 (Pubitemid 351697556)
3. Poncet C., Frances V., Gristina R., Scheiner C., Pellissier J. F., Figarella-Branger D., CD24, a glycosylphosphatidylinositol-anchored molecule, is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors Acta Neuropathologica 1996 91 4 400 408
4. Overdevest J. B., Thomas S., Kristiansen G., Hansel D. E., Smith S. C., Theodorescu D., CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization Cancer Research 2011 71 11 3802 3811
5. Taniuchi K., Nishimori I., Hollingsworth M. A., Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP Cancer Research 2011 71 3 895 905
6. Myung J. H., Gajjar K. A., Pearson R. M., Launiere C. A., Eddington D. T., Hong S., Direct measurements on CD24-mediated rolling of human breast cancer MCF-7 cells on E-selectin Analytical Chemistry 2011 83 3 1078 1083
7. Pass M. K., Quintini G., Zarn J. A., Zimmermann S. M., Sigrist J. A., Stahel R. A., The 5'-flanking region of human CD24 gene has cell-type-specific promoter activity in small-cell lung cancer International Journal of Cancer 1998 78 4 496 502 (Pubitemid 28481170)
8. Sano A., Kato H., Sakurai S., Sakai M., Tanaka N., Inose T., Saito K., Sohda M., Nakajima M., Nakajima T., Kuwano H., CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma Annals of Surgical Oncology 2009 16 2 506 514
9. Huang L. R., Hsu H. C., Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation Cancer Research 1995 55 20 4717 4721
10. Choi Y. L., Kim S. H., Shin Y. K., Hong Y. C., Lee S. J., Kang S. Y., Ahn G., Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors Gynecologic Oncology 2005 97 2 379 386 (Pubitemid 40614878)
11. Senner V., Sturm A., Baur I., Schrell U. H. M., Distel L., Paulus W., CD24 promotes invasion of glioma cells in vivo Journal of Neuropathology and Experimental Neurology 1999 58 8 795 802 (Pubitemid 29372834)
12. Louis D. N., Ohgaki H., Wiestler O. D., Cavenee W. K., Burger P. C., Jouvet A., Scheithauer B. W., Kleihues P., The 2007 WHO classification of tumours of the central nervous system Acta Neuropathologica 2007 114 2 97 109 (Pubitemid 47103521)
13. Nakada M., Drake K. L., Nakada S., Niska J. A., Berens M. E., Ephrin-B3 ligand promotes glioma invasion through activation of Rac1 Cancer Research 2006 66 17 8492 8500 (Pubitemid 44449162)
14. Brown R. S., Wahl R. L., Overexpression of Glut-1 glucose transporter in human breast cancer: an immunohistochemical study Cancer 1993 72 10 2979 2985 (Pubitemid 23335044)
15. Shapira S., Shapira A., Starr A., Kazanov D., Kraus S., Benhar I., Arber N., An immunoconjugate of Anti-CD24 and pseudomonas exotoxin selectively kills human colorectal tumors in mice Gastroenterology 2011 140 3 935 946
16. Horiguchi K., Toi M., Horiguchi S. I., Sugimoto M., Naito Y., Hayashi Y., Ueno T., Ohno S., Funata N., Kuroi K., Tomita M., Eishi Y., Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients Journal of Medical and Dental Sciences 2010 57 2 165 175
17. Kim H. J., Kim M. J., Ahn S. H., Son B. H., Kim S. B., Ahn J. H., Noh W. C., Gong G., Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status Breast 2011 20 78 85
18. Lee H. J., Choe G., Jheon S., Sung S. W., Lee C. T., Chung J. H., CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (Seventh) New TNM classification Journal of Thoracic Oncology 2010 5 5 649 657
19. Kristiansen G., MacHado E., Bretz N., Rupp C., Winzer K. J., Knig A. K., Moldenhauer G., Marmé F., Costa J., Altevogt P., Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis Laboratory Investigation 2010 90 7 1102 1116
20. Wang W., Wang X., Peng L., Deng Q., Liang Y., Qing H., Jiang B., CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation Cancer Science 2010 101 1 112 119
21. Su D., Deng H., Zhao X., Zhang X., Chen L., Chen X., Li Z., Bai Y., Wang Y., Zhong Q., Yi T., Qian Z., Wei Y., Targeting CD24 for treatment of ovarian cancer by short hairpin RNA Cytotherapy 2009 11 5 642 652
22. Kristiansen G., Schlns K., Yongwei Y., Denkert C., Dietel M., Petersen I., CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients British Journal of Cancer 2003 88 2 231 236 (Pubitemid 36255841)
23. Athanassiadou P., Grapsa D., Gonidi M., Athanassiadou A. M., Tsipis A., Patsouris E., CD24 expression has a prognostic impact in breast carcinoma Pathology Research and Practice 2009 205 8 524 533
24. Su M. C., Hsu C., Kao H. L., Jeng Y. M., CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma Cancer Letters 2006 235 1 34 39
25. Yang X. R., Xu Y., Yu B., Zhou J., Li J. C., Qiu S. J., Shi Y. H., Wang X. Y., Dai Z., Shi G. M., Wu B., Wu L. M., Yang G. H., Zhang B. H., Qin W. X., Fan J., CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery Clinical Cancer Research 2009 15 17 5518 5527
26. Sagiv E., Arber N., The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy Expert Review of Gastroenterology and Hepatology 2008 2 1 125 133
27. Fvre-Montange M., Champier J., Szathmari A., Wierinckx A., Mottolese C., Guyotat J., Figarella-Branger D., Jouvet A., Lachuer J., Microarray analysis reveals differential gene expression patterns in tumors of the pineal region Journal of Neuropathology and Experimental Neurology 2006 65 7 675 684 (Pubitemid 44297258)
28. Lo H. W., Zhu H., Cao X., Aldrich A., Ali-Osman F., A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion Cancer Research 2009 69 17 6790 6798